QL Biotech takes pride in presenting our state-of-the-art Serum Amyloid A Semi-Quantitative Rapid Test Device, designed specifically for whole blood, serum, and plasma samples. This innovative diagnostic tool is tailored for the rapid and accurate detection of canine parvovirus and coronavirus antigen. Commonly abbreviated as SAA, Serum Amyloid A is typically complexed with lipoproteins in its natural state, and its isoforms differ across species. This SAA Test Device utilizes this intricate biology to identify and measure the level of infection in animals. The detection of canine parvovirus and coronavirus antigen is a critical step in the diagnosis and treatment of these highly contagious diseases. These viruses pose significant health risks to dogs, often resulting in severe and potentially fatal illnesses. Early and accurate detection is of the essence in controlling the spread and initiating appropriate veterinary care.



Our test device leverages advancements in biotechnology to deliver rapid, semi-quantitative results, providing precise insights to help guide clinical decisions. A key feature of our SAA Test Device is its ability to detect both parvovirus and coronavirus antigens simultaneously, enhancing its utility in a veterinary setting. Moreover, being a semi-quantitative test allows veterinarians to monitor the progression of the disease and evaluate the response to treatment. QL Biotech aims to support veterinarians in their mission to provide quality healthcare to our furry friends through reliable, swift, and accurate diagnostic tools. Choose us for comprehensive, prompt, and accurate detection of canine parvovirus and coronavirus antigen – taking a revolutionary stride in animal healthcare.